Tumor antigen mimetic

**Tumor antigen mimetic** refers to a class of molecules designed to imitate tumor antigens or the functional activity of tumor suppressor proteins in cancer therapy. Unlike conventional therapeutic targets such as receptors or enzymes, tumor antigen mimetics do not have a unique molecular identity but are developed to elicit immune or cell-inhibitory responses against tumor cells. They can be:\n- Mimics of carbohydrate or protein antigens exposed on tumor cell surfaces (to stimulate antibody/T-cell immune responses)\n- Small molecule or biologic mimetics that replace the function of epigenetically silenced tumor suppressor proteins\n- Peptidomimetics engineered through structural or functional similarities to tumor antigens, intended for vaccine or immunotherapeutic use\n\nThis means "tumor antigen mimetic" is best understood as a developmental category for anti-cancer drugs and vaccines, not a specific molecular target[1][2][3][4].

Other names

Tumor antigen mimicTumor-associated antigen mimeticCarbohydrate-mimetic peptide (CMP)

Mimic tumor antigens to provoke immune responses against cancer cells\nReplace or restore suppressed tumor suppressor gene (TSG) function using mimetic molecules\nStimulate T-cell or antibody-mediated tumor cell killing